ORIC Pharmaceuticals, Inc.
DE ˙ DB ˙ US68622P1093
6,51 € ↑0,13 (2,10%)
2026-06-04
DELAT PRIS
SecurityDE:4TZ / ORIC Pharmaceuticals, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership1,682,523 shares
Latest Disclosed Value $ 21,317,567
Morgan Stanley reports 40.91% increase in ownership of 4TZ / ORIC Pharmaceuticals, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 1,682,523 shares of ORIC Pharmaceuticals, Inc. (DE:4TZ) valued at $18,339,501 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 1,194,073 shares of ORIC Pharmaceuticals, Inc.. This represents a change in shares of 40.91% during the quarter. The current value of the position is $10,956,590 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 1,682,523 488,450 40.91 21,318 118.26 0.0013
2026-05-27 2025-12-31 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 1,194,073 448,545 60.16 9,768 9.18 0.0006
2026-02-13 2025-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 1,194,073 448,545 9,768 0.0006
2026-05-27 2025-09-30 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 745,528 350,743 88.84 8,946 123.26 0.0005
2025-11-14 2025-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 745,528 350,743 8,946 0.0005
2025-08-15 2025-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 394,785 226,114 134.06 4,007 325.82 0.0003
2025-05-15 2025-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 168,671 -178,684 -51.44 941 -66.43 0.0001
2025-05-15 2024-12-31 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 347,355 -24,372 -6.56 2,803 -26.43 0.0002
2025-02-14 2024-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 347,355 -24,372 2,803 0.0002
2025-05-14 2024-09-30 13F/A-2 ORIC PHARMACEUTICALS COM 68622P109 371,727 -52,195 -12.31 3,810 27.13 0.0003
2025-02-14 2024-09-30 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 371,727 -52,195 3,810 0.0003
2024-11-14 2024-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 371,727 -52,195 3,810 0.0000
2025-05-14 2024-06-30 13F/A-2 ORIC PHARMACEUTICALS COM 68622P109 423,922 123,099 40.92 2,997 -27.54 0.0002
2024-10-17 2024-06-30 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 423,922 123,099 2,997 0.0002
2024-08-14 2024-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 423,922 123,099 2,997 0.0002
2024-10-17 2024-03-31 13F/A-2 ORIC PHARMACEUTICALS COM 68622P109 300,823 -179,508 -37.37 4,136 -6.40 0.0003
2024-08-16 2024-03-31 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 300,823 -179,508 4,136 0.0000
2024-05-15 2024-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 300,823 -179,508 4,136 0.0003
2024-08-16 2023-12-31 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 480,331 356,140 286.77 4,419 488.42 0.0004
2024-02-13 2023-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 480,331 356,140 4,419 0.0004
2023-11-15 2023-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 124,191 -24,390 -16.42 751 -34.81 0.0001
2023-08-14 2023-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 148,581 54,552 58.02 1,153 115.33 0.0001
2023-05-15 2023-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 94,029 36,454 63.32 536 57.82 0.0001
2023-02-14 2022-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 57,575 19,885 52.76 339 180.17 0.0000
2022-11-14 2022-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 37,690 -41,513 -52.41 121 -65.82 0.0000
2022-10-27 2022-06-30 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 79,203 6,006 8.21 354 -9.46 0.0000
2022-08-15 2022-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 79,203 6,006 354 0.0000
2022-10-27 2022-03-31 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 73,197 26,830 57.86 391 -42.58 0.0001
2022-05-13 2022-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 73,197 26,830 391 0.0001
2022-02-14 2021-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 46,367 27,453 145.15 681 71.97 0.0001
2021-11-15 2021-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 18,914 -127,101 -87.05 396 -84.66 0.0001
2021-08-23 2021-06-30 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 146,015 133,130 1,033.22 2,582 717.09 0.0003
2021-08-16 2021-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 146,015 133,130 2,582 0.0001
2021-05-17 2021-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 12,885 -18,324 -58.71 316 -70.08 0.0000
2021-02-16 2020-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 31,209 30,270 3,223.64 1,056 4,491.30 0.0002
2020-11-13 2020-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 939 -1,914 -67.09 23 -76.04 0.0000
2020-08-14 2020-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 2,853 2,853 96 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.